Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Glycoprotein B (EBV)

Glycoprotein B (EBV)

Brief Information

Name:Envelope glycoprotein B, gB
Target Synonym:UL55
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GLB-E52H3 Epstein-Barr virus Epstein-Barr virus Envelope Glycoprotein B (gB), His Tag (MALS verified)
GLB-E52H3-sds
ACRO Quality

Part of Bioactivity data

GLB-E52H3-MALS-HPLC
Glycoprotein B (EBV) MALS images

The purity of Epstein-Barr virus Envelope Glycoprotein B (gB), His Tag (Cat. No. GLB-E52H3) is more than 85% and the molecular weight of this protein is around 275-305 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Fiztasovimab NPC-21 Phase 2 Clinical Cytomegalovirus Infections Details
TRL-345 CMV-345; TRL-345 Phase 1 Clinical Trellis Bioscience LLC Cytomegalovirus Infections Details
Fiztasovimab NPC-21 Phase 2 Clinical Cytomegalovirus Infections Details
TRL-345 CMV-345; TRL-345 Phase 1 Clinical Trellis Bioscience LLC Cytomegalovirus Infections Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message